News | Cardiovascular Business | October 20, 2022

Atlas Healthcare Partners and MedAxiom Unveil Cardiovascular ASC Solution, MedAtlas CV

MedAtlas CV will transform cardiovascular care delivery and expand patient access

MedAtlas CV will transform cardiovascular care delivery and expand patient access

October 20, 2022 — Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers (ASCs) – and MedAxiom – which is dedicated to cardiovascular organizational performance improvement –announced the unveiling of its new joint venture, MedAtlas CV. In June, Atlas and MedAxiom partnered to form a cardiovascular-focused ASC company that will transform cardiovascular care by expanding access to high-quality, patient-centered heart care in ASCs. The launch of MedAtlas CV represents a crucial shift in access to and delivery of expert cardiovascular care. 

"We are thrilled with the launch of MedAtlas CV as it showcases how the new company will transform cardiovascular care delivery and expand patient access by providing the best patient and provider experience, driving efficient ASC performance, and delivering high-quality cardiovascular care in ASCs," said Marc Toth, Atlas market president for cardiovascular. 

"MedAtlas CV will provide a better experience for physicians and patients through strategic alignments, including bridging the gap between health systems and physicians," said Jerry Blackwell, MD, MBA, FACC, MedAxiom president and CEO. "The combination of Atlas' expertise in ASC development and management, and MedAxiom's deep insights into cardiovascular care delivery, ensures high-quality clinical and patient outcomes." 

For more information: medatlascv.com 


Related Content

Feature | Cardiovascular Business | By Merilee Kern, MBA

Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of ...

Home November 09, 2022
Home
News | Cardiovascular Business

November 1, 2022 — Deepak L. Bhatt, MD, MPH, a top expert in cardiovascular medicine and interventional cardiology, has ...

Home November 01, 2022
Home
Feature | Cardiovascular Business

November 1, 2022 — Johnson & Johnson and Abiomed, a world leader in breakthrough heart, lung and kidney support ...

Home November 01, 2022
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the fields of diagnostic and interventional ...

Home November 01, 2022
Home
News | Cardiovascular Business

October 31, 2022 — The Yale School of Medicine announced the passing of Robert W. Berliner Professor Emeritus of ...

Home October 31, 2022
Home
News | Cardiovascular Business

October 24, 2022 — Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine ...

Home October 24, 2022
Home
News | Cardiovascular Business

October 19, 2022 — Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named ...

Home October 19, 2022
Home
News | Cardiovascular Business

October 12, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...

Home October 12, 2022
Home
News | Cardiovascular Business

October 6, 2022 – OpSens Inc., a Quebec-based medical device cardiology-focused company, has announced that it has ...

Home October 06, 2022
Home
News | Cardiovascular Business

October 5, 2022 — University Hospitals (UH) Harrington Heart & Vascular Institute has a rich history of providing the ...

Home October 05, 2022
Home
Subscribe Now